The clinical significance of 5% and 10% weight loss
NHS and NICE guidance highlights 5–10% of initial body weight as a clinically meaningful target independent of absolute BMI reached. A 5% reduction in body weight produces statistically significant improvements in fasting blood glucose, triglycerides, blood pressure, and insulin sensitivity in overweight and obese individuals. A 10% reduction produces larger effects and can substantially reduce the 10-year risk of type 2 diabetes in people with prediabetes.
These percentage targets are often more motivating and achievable in the short term than targeting a specific BMI category. A person with an initial BMI of 38 who achieves 10% weight loss moves to a BMI of approximately 34 — still in the obese range, but with clinically significant metabolic improvement and a meaningful reduction in cardiovascular risk. The BMI milestone targets (BMI 30, BMI 25, target BMI) provide longer-horizon goals for sustained effort.